Alternative links to fulltext:
| Item type: | Article | ||||
|---|---|---|---|---|---|
| Journal or Publication Title: | Cancer treatment reviews | ||||
| Publisher: | Elsevier | ||||
| Volume: | 14 | ||||
| Number of Issue or Book Chapter: | 3-4 | ||||
| Page Range: | pp. 275-283 | ||||
| Date: | 1987 | ||||
| Additional Information (public): | CAN 108:215908 1-6 Pharmacology 15663-27-1 (Cisplatin); 105856-23-3; 105856-32-4; 111086-58-9 Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (antitumor activity of, for mammary carcinoma, pharmacol. in relation to); 15663-27-1D (Cisplatin) Role: BIOL (Biological study) (estrophilic, mammary carcinoma growth inhibition by and pharmacol. of) | ||||
| Institutions: | Chemistry and Pharmacy > Institute of Pharmacy > Alumni or Retired Professors > Prof. Schönenberger | ||||
| Projects (Historical): | SFB 234 | ||||
| Identification Number: |
| ||||
| Keywords: | Neoplasm inhibitors (carcinoma, cisplatin derivs. as, for mammary gland) Mammary gland (neoplasm, carcinoma, therapy of, cisplatin derivs. for) carcinoma mammary cisplatin review cisplatin antitumor platinum complex antitumor | ||||
| Dewey Decimal Classification: | 500 Science > 540 Chemistry & allied sciences | ||||
| Status: | Published | ||||
| Refereed: | Yes, this version has been refereed | ||||
| Created at the University of Regensburg: | Yes | ||||
| Item ID: | 17661 |
Abstract
A discussion on cisplatin derivs. for mammary carcinoma therapy is given. Toxicity and metab. are also discussed.
Metadata last modified: 24 May 2018 12:18
Owner only: item control page
Altmetric
Altmetric